Literature DB >> 9673245

Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.

M M Prendergast1, A J Lastovica, A P Moran.   

Abstract

Three Campylobacter jejuni, biotype 2, serotype O:41 strains that were isolated from patients who developed Guillain-Barré syndrome (GBS) and one C. jejuni isolate from a patient who developed enteritis only were examined. The aim of the study was to determine the structure of the core oligosaccharide (OS) of the lipopolysaccharide (LPS) of C. jejuni serotype O:41, a serotype rarely associated with the development of GBS, and to determine if the LPS shares similar epitopes with any of the major human gangliosides. Electrophoretic analysis with silver staining or immunoblotting demonstrated that the strains had LPS profiles characteristic of low-molecular-weight LPS. Colorimetric analysis detected N-acetylneuraminic (sialic) acid in the core OSs of all the strains. Thin-layer chromatography with immunostaining showed that antisera raised against the GBS strains reacted with the GM1 ganglioside, suggesting that C. jejuni serotype O:41 LPSs and the GM1 ganglioside have similar epitopes. Furthermore, polyclonal anti-GM1 and anti-asialoGM1 antibodies cross-reacted with each C. jejuni O:41 LPS tested, suggesting that the serotype O:41 core OS has a GM1- and asialoGM1-like structure. LPSs extracted from C. jejuni serostrains O:2, O:3, and O:19 were also used in the study. Cholera toxin (a GM1 ligand) and peanut agglutinin (a Galbeta1-3GalNAc ligand) recognized all serotype O:41 LPSs and the serostrain O:2 LPS. Immunoadsorption results confirmed GM1 relatedness. Moreover, the core OS was isolated from a GBS-associated C. jejuni O:41 LPS by gel permeation chromatography. An analysis by gas-liquid chromatography (GLC), GLC-mass spectrometry, and nuclear magnetic resonance showed the core OS of one of the C. jejuni O:41 GBS isolates to have a tetrasaccharide structure consistent with GM1 mimicry.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673245      PMCID: PMC108398     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni and Campylobacter coli.

Authors:  A P Moran; T U Kosunen
Journal:  APMIS       Date:  1989-03       Impact factor: 3.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Campylobacter jejuni and Guillain-Barré syndrome.

Authors:  J H Rees; R A Hughes
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

4.  Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.

Authors:  A J Lastovica; E A Goddard; A C Argent
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

Review 5.  Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome.

Authors:  B Mishu; M J Blaser
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

6.  Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni.

Authors:  M A Preston; J L Penner
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

7.  Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope.

Authors:  N Yuki; T Taki; M Takahashi; K Saito; T Tai; T Miyatake; S Handa
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Biochemical characterization of Campylobacter fetus lipopolysaccharides.

Authors:  A P Moran; D T O'Malley; T U Kosunen; I M Helander
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides.

Authors:  G O Aspinall; A G McDonald; T S Raju; H Pang; A P Moran; J L Penner
Journal:  Eur J Biochem       Date:  1993-05-01

10.  Inactivation of Campylobacter jejuni flagellin genes by homologous recombination demonstrates that flaA but not flaB is required for invasion.

Authors:  T M Wassenaar; N M Bleumink-Pluym; B A van der Zeijst
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  22 in total

Review 1.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

2.  Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources.

Authors:  Craig T Parker; Sharon T Horn; Michel Gilbert; William G Miller; David L Woodward; Robert E Mandrell
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Whole genome comparison of Campylobacter jejuni human isolates using a low-cost microarray reveals extensive genetic diversity.

Authors:  N Dorrell; J A Mangan; K G Laing; J Hinds; D Linton; H Al-Ghusein; B G Barrell; J Parkhill; N G Stoker; A V Karlyshev; P D Butcher; B W Wren
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

4.  Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Authors:  Patricia Guerry; Christine M Szymanski; Martina M Prendergast; Thomas E Hickey; Cheryl P Ewing; Dawn L Pattarini; Anthony P Moran
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study.

Authors:  Joachim Schessl; Birgit Luther; Janbernd Kirschner; Gottfried Mauff; Rudolf Korinthenberg
Journal:  Eur J Pediatr       Date:  2006-05-12       Impact factor: 3.183

Review 6.  Human innate B cells: a link between host defense and autoimmunity?

Authors:  Eric C B Milner; Jennifer Anolik; Amedeo Cappione; Iñaki Sanz
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

7.  Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.

Authors:  Peggy C R Godschalk; Mark L Kuijf; Jianjun Li; Frank St Michael; C Wim Ang; Bart C Jacobs; Marie-France Karwaski; Denis Brochu; Ali Moterassed; Hubert P Endtz; Alex van Belkum; Michel Gilbert
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

8.  Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

Authors:  P Guerry; C P Ewing; T E Hickey; M M Prendergast; A P Moran
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.

Authors:  Maojun Zhang; Lihua He; Qun Li; Honghe Sun; Yixin Gu; Yuanhai You; Fanliang Meng; Jianzhong Zhang
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection.

Authors:  Martina M Prendergast; David R Tribble; Shahida Baqar; Daniel A Scott; John A Ferris; Richard I Walker; Anthony P Moran
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.